These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 21249329)

  • 1. Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies.
    Van Craeyveld E; Gordts SC; Nefyodova E; Jacobs F; De Geest B
    J Mol Med (Berl); 2011 Jun; 89(6):555-67. PubMed ID: 21249329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenoviral low density lipoprotein receptor attenuates progression of atherosclerosis and decreases tissue cholesterol levels in a murine model of familial hypercholesterolemia.
    Jacobs F; Van Craeyveld E; Feng Y; Snoeys J; De Geest B
    Atherosclerosis; 2008 Dec; 201(2):289-97. PubMed ID: 18378244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid lowering and HDL raising gene transfer increase endothelial progenitor cells, enhance myocardial vascularity, and improve diastolic function.
    Gordts SC; Van Craeyveld E; Muthuramu I; Singh N; Jacobs F; De Geest B
    PLoS One; 2012; 7(10):e46849. PubMed ID: 23056485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient Mice.
    Willecke F; Yuan C; Oka K; Chan L; Hu Y; Barnhart S; Bornfeldt KE; Goldberg IJ; Fisher EA
    PLoS One; 2015; 10(6):e0128996. PubMed ID: 26046657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein AI) Promotes Atherosclerosis Regression in Diabetic Mice by Suppressing Myelopoiesis and Plaque Inflammation.
    Barrett TJ; Distel E; Murphy AJ; Hu J; Garshick MS; Ogando Y; Liu J; Vaisar T; Heinecke JW; Berger JS; Goldberg IJ; Fisher EA
    Circulation; 2019 Oct; 140(14):1170-1184. PubMed ID: 31567014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of selective HDL-raising gene transfer on survival, cardiac remodelling and cardiac function after myocardial infarction in mice.
    Gordts SC; Muthuramu I; Nefyodova E; Jacobs F; Van Craeyveld E; De Geest B
    Gene Ther; 2013 Nov; 20(11):1053-61. PubMed ID: 23759702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficient mice.
    MacDougall ED; Kramer F; Polinsky P; Barnhart S; Askari B; Johansson F; Varon R; Rosenfeld ME; Oka K; Chan L; Schwartz SM; Bornfeldt KE
    Am J Pathol; 2006 Jun; 168(6):2064-73. PubMed ID: 16723719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein A-I and lecithin:cholesterol acyltransferase transfer induce cholesterol unloading in complex atherosclerotic lesions.
    Van Craeyveld E; Lievens J; Jacobs F; Feng Y; Snoeys J; De Geest B
    Gene Ther; 2009 Jun; 16(6):757-65. PubMed ID: 19242527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia.
    Belalcazar LM; Merched A; Carr B; Oka K; Chen KH; Pastore L; Beaudet A; Chan L
    Circulation; 2003 Jun; 107(21):2726-32. PubMed ID: 12742997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effects of Diet-Induced Lipid Lowering Versus Lipid Lowering Along With Apo A-I Milano Gene Therapy on Regression of Atherosclerosis.
    Wang L; Tian F; Arias A; Yang M; Sharifi BG; Shah PK
    J Cardiovasc Pharmacol Ther; 2016 May; 21(3):320-8. PubMed ID: 26499098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis.
    Jacobs F; Van Craeyveld E; Muthuramu I; Gordts SC; Emmerechts J; Hoylaerts M; Herijgers P; De Geest B
    J Mol Med (Berl); 2011 Oct; 89(10):1051-8. PubMed ID: 21688073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Transcription Factor CREBH Accelerates Diet-Induced Atherosclerosis in Ldlr-/- Mice.
    Park JG; Xu X; Cho S; Lee AH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1772-81. PubMed ID: 27417587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor.
    Masson D; Koseki M; Ishibashi M; Larson CJ; Miller SG; King BD; Tall AR
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2054-60. PubMed ID: 19815817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term reversal of hypercholesterolemia in low density lipoprotein receptor (LDLR)-deficient mice by adenovirus-mediated LDLR gene transfer combined with CD154 blockade.
    Stein CS; Martins I; Davidson BL
    J Gene Med; 2000; 2(1):41-51. PubMed ID: 10765504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene transfer and hepatic overexpression of the HDL receptor SR-BI reduces atherosclerosis in the cholesterol-fed LDL receptor-deficient mouse.
    Kozarsky KF; Donahee MH; Glick JM; Krieger M; Rader DJ
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):721-7. PubMed ID: 10712397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor.
    Basu D; Hu Y; Huggins LA; Mullick AE; Graham MJ; Wietecha T; Barnhart S; Mogul A; Pfeiffer K; Zirlik A; Fisher EA; Bornfeldt KE; Willecke F; Goldberg IJ
    Circ Res; 2018 Feb; 122(4):560-567. PubMed ID: 29321129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor.
    Kobayashi K; Oka K; Forte T; Ishida B; Teng B; Ishimura-Oka K; Nakamuta M; Chan L
    J Biol Chem; 1996 Mar; 271(12):6852-60. PubMed ID: 8636110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice.
    Leggiero E; Astone D; Cerullo V; Lombardo B; Mazzaccara C; Labruna G; Sacchetti L; Salvatore F; Croyle M; Pastore L
    Gene Ther; 2013 Dec; 20(12):1124-30. PubMed ID: 23883962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adeno-associated virus serotype 8 ApoA-I gene transfer reduces progression of atherosclerosis in ApoE-KO mice: comparison of intramuscular and intravenous administration.
    Cimmino G; Giannarelli C; Chen W; Alique M; Santos-Gallego CG; Fuster V; Hajjar RJ; Walsh CE; Badimon JJ
    J Cardiovasc Pharmacol; 2011 Mar; 57(3):325-33. PubMed ID: 21164355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.